Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Current Leases: 2019-2024

Historic Current Leases for Lifecore Biomedical (LFCR) over the last 6 years, with May 2024 value amounting to $4.0 million.

  • Lifecore Biomedical's Current Leases fell 4.64% to $4.0 million in Q1 2025 from the same period last year, while for Feb 2025 it was $4.0 million, marking a year-over-year decrease of 4.64%. This contributed to the annual value of $4.0 million for FY2024, which is 212.05% up from last year.
  • Per Lifecore Biomedical's latest filing, its Current Leases stood at $4.0 million for FY2024, which was up 212.05% from $1.3 million recorded in FY2023.
  • Lifecore Biomedical's Current Leases' 5-year high stood at $4.4 million during FY2020, with a 5-year trough of $977,000 in FY2021.
  • In the last 3 years, Lifecore Biomedical's Current Leases had a median value of $4.0 million in 2024 and averaged $3.2 million.
  • Per our database at Business Quant, Lifecore Biomedical's Current Leases surged by 5,797.33% in 2020 and then crashed by 77.91% in 2021.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Current Leases stood at $4.4 million in 2020, then plummeted by 77.91% to $977,000 in 2021, then soared by 347.08% to $4.4 million in 2022, then plummeted by 70.92% to $1.3 million in 2023, then spiked by 212.05% to $4.0 million in 2024.